2023
DOI: 10.3390/ijms241713083
|View full text |Cite
|
Sign up to set email alerts
|

Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19

Zoia R. Korobova,
Natalia A. Arsentieva,
Areg A. Totolian

Abstract: Macrophage-derived chemokine (MDC/CCL22) is a chemokine of the C-C subfamily. It is involved in T-cellular maturation and migration. Our previous research shows that plasma CCL22/MDC tends to show a statistically significant depletion of concentrations in acute patients and convalescents when compared to healthy donors. In the current work, we investigate existing views on MDC/CCL22 dynamics in association with various pathologies, including respiratory diseases and, specifically, COVID-19. Additionally, we pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 68 publications
2
0
0
Order By: Relevance
“…This was supported by the transwell migration assay, which showed a notable increase in TD cell count in the OGD media. This is consistent with previous studies reporting the importance of the CCL22-CCR4 interaction in Treg cell migration 29,39,41 , suggesting the therapeutic potential of Treg cells to reduce ischemic damage and promote recovery in the brain post-stroke. Taken together, the importance of the CCL22-CCR4 interaction in reducing stroke severity via Treg cell recruitment may be a potent candidate for cell therapy.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…This was supported by the transwell migration assay, which showed a notable increase in TD cell count in the OGD media. This is consistent with previous studies reporting the importance of the CCL22-CCR4 interaction in Treg cell migration 29,39,41 , suggesting the therapeutic potential of Treg cells to reduce ischemic damage and promote recovery in the brain post-stroke. Taken together, the importance of the CCL22-CCR4 interaction in reducing stroke severity via Treg cell recruitment may be a potent candidate for cell therapy.…”
Section: Discussionsupporting
confidence: 93%
“…CCL22 is an effective chemoattractant for Treg cells and is secreted by monocytes 39 , which is in agreement with the chemokine profiling array results shown in this study. Notably, a few studies have shown a significant reduction in CCL22 levels during the acute phase of ischemic stroke in the circulation and infarct core, resulting in a higher National Institute of Health Stroke Scale (NIHSS) 40 .…”
Section: Discussionsupporting
confidence: 92%
“… 325 , 326 In addition to intracellular killing mechanisms, M1 macrophages employ extracellular strategies to combat pathogens, such as neutrophil extracellular trap formation, antimicrobial peptide and enzyme secretion, and cytokine and chemokine production to recruit and activate additional immune cells. 327 , 328 , 329 , 330 …”
Section: Macrophages: Orchestrators Of Tissue Repair and Regenerationmentioning
confidence: 99%